Evidence map›Paper›PMID 28389796›Full record

SynthesisSurgical endoscopy2017

Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis.

Benbo Zheng, Rongce Zhao, Xiaodong Li, Bo Li

Registry-linked trialAbstract readComparative StudyMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Surgical endoscopy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03270917 (The ORANGE SEGMENTS - Trial), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03270917 naactive not recruitingnot on this map

The ORANGE SEGMENTS - Trial: an International Multicentre Randomized Controlled Trial of Open Versus Laparoscopic Parenchymal Preserving Postero-superior Liver Segment Resection

TypeinterventionalSponsorMaastricht University Medical CenterRan2017 to 2026Enrolled250ConditionsLiver SurgeryArmsParenchymal preserving postero-superior liver segment resection
3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Robot-assisted liver resection: the real benefit so far.Langenbeck's archives of surgery · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Benbo ZhengDepartment of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Deyang, Deyang, 618000, Sichuan, China.
Rongce ZhaoDepartment of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, No. 37 Guoxuexiang, Chengdu, 610041, Sichuan Province, China. zhaorongce@163.com.
Xiaodong LiDepartment of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Deyang, Deyang, 618000, Sichuan, China.
Bo LiDepartment of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, No. 37 Guoxuexiang, Chengdu, 610041, Sichuan Province, China. cdlibo168@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLaparoscopic liver resection (LLR) is mostly performed to treat benign lesions at easily accessible locations. With improvements in instruments and accumulation of experience, LLR has evolved to treat malignant tumors with major hepatectomy, even in less accessible locations, without compromising the principles of safety and oncology. The present meta-analysis aimed to compare the outcomes of LLR for lesions located in anterolateral (AL) (II, III, IVb, V, and VI) and posterosuperior (PS) (I, IVa, VII, and VIII) liver segments.

methodsA comprehensive search was conducted to identify all eligible studies. This meta-analysis was performed using the STATA 12.0 statistical software. Standardized mean differences (SMDs) and odds ratios (ORs) were calculated for continuous variables and dichotomous variables, respectively, with 95% confidence intervals (CIs).

resultsA total of 846 patients from five studies were identified for the final analysis, with 565 patients in the AL group and 281 in the PS group. Although the operation time (SMD -0.60; 95% CI -0.75 to -0.45; P = 0.000) and conversion rate (OR 0.40; 95% CI 0.24-0.67; P = 0.000) were lower and the resection margin was wider (SMD 0.2; 95% CI 0.03-0.37; P = 0.019) in the AL group than in the PS group, no significant differences in blood loss (SMD -0.29; 95% CI -0.68 to 0.09; P = 0.131), complication rate (OR 0.73; 95% CI 0.50-1.07; P = 0.103), hospital stay (SMD -0.53; 95% CI -1.16 to 0.11; P = 0.105), and tumor recurrence (OR 1.23; 95% CI 0.81-1.86; P = 0.334) were noted between the groups.

conclusionLLR is technically feasible and safe for selected patients with lesions in the PS segments of the liver.

Indexed as

Conversion to Open SurgeryHepatectomyHumansLaparoscopyLength of StayLiverLiver NeoplasmsNeoplasm Recurrence, LocalOperative TimePostoperative ComplicationsTreatment OutcomeAnterolateralLaparoscopic liver resectionMeta-analysisPosterosuperior

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.